Apitolisib
CAS: 1032754-93-0
Ref. TM-T1916
| 2mg | 45.00 € | ||
| 5mg | 63.00 € | ||
| 10mg | 96.00 € | ||
| 25mg | 155.00 € | ||
| 50mg | 242.00 € | ||
| 100mg | 397.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Product Information
Name:
Apitolisib
Synonyms:
- RG 7422
- GNE 390
- GDC-0980
- Gdc-0980
- Gne 390
- (S)-1-(4-((2-(2-aMinopyriMidin-5-yl)-7-Methyl-4-Morpholinothieno[3,2-d]pyriMidin-6-yl)Methyl)piperazin-1-yl)-2-hydroxypropan-1-one
- Gdc-0980 (Rg7422)
- (2S)-1-(4-{[2-(2-Amino-5-pyrimidinyl)-7-methyl-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl}-1-piperazinyl)-2-hydroxy-1-propanone
Description:
Apitolisib (RG 7422) is a PI3K inhibitor, used in cancer trials, targeting PI3Kα, β, δ, γ (IC50= 5, 27, 7, 14 nM).
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
498.6
Formula:
C23H30N8O3S
Purity:
98.28% - 99.52%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T1916 Apitolisib
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
